Applied Materials Maintains Q1 Outlook Despite New US Semiconductor Export Regulations-January 2024-www.financetom.com

Applied Materials Maintains Q1 Outlook Despite New US Semiconductor Export Regulations

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Applied Materials Maintains Q1 Outlook Despite New US Semiconductor Export Regulations

Dec 3, 2024 5:36 AM

08:08 AM EST, 12/03/2024 (MT Newswires) -- Applied Materials ( AMAT ) said Tuesday that it will not change the guided ranges for its fiscal Q1 2025 outlook that was provided on Nov. 14 despite new export regulations announced by the U.S. government for semiconductor technology.

The company previously said it expects fiscal Q1 adjusted EPS of $2.29, plus or minus $0.18, on net revenue of $7.15 billion, plus or minus $400 million.

Previous page： Delaware Judge Dismisses Complaint Against Meta Platforms Next page： Cannabis Stocks Rise on Media Report of DEA Reclassifying Marijuana as Less Dangerous Drug

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Delaware Judge Dismisses Complaint Against Meta Platforms

Apr 30, 2024

02:38 PM EDT, 04/30/2024 (MT Newswires) -- Meta Platforms ( META ) won a victory Tuesday in the Delaware Court of Chancery when Vice Chancellor J. Travis Laster dismissed a complaint from a shareholder activist that claimed that the company's pursuit of profits jeopardized public safety, social well-being, and its stockholders' diversified portfolios. The complaint failed to make a compelling...

Cannabis Stocks Rise on Media Report of DEA Reclassifying Marijuana as Less Dangerous Drug

Apr 30, 2024

02:42 PM EDT, 04/30/2024 (MT Newswires) -- Cannabis stocks were up in trading Tuesday after the Associated Press reported that the US Drug Enforcement Administration planned to reclassify marijuana as a drug that posed lesser harm than other substances. The DEA's plan to bump marijuana down to the Schedule III category from its current Schedule I status would require approval...

Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance

Apr 30, 2024

02:31 PM EDT, 04/30/2024 (MT Newswires) -- Medifast ( MED ) shares were more than 18% in recent trading on Tuesday, a day after the company's Q1 adjusted earnings miss consensus. The company reported Q1 adjusted earnings Monday of $0.66 per diluted share, down from $3.67 a year earlier. Analysts polled by Capital IQ expected $0.80 per share. Revenue for...

Top Midday Gainers

Apr 30, 2024

02:37 PM EDT, 04/30/2024 (MT Newswires) -- Cyclacel Pharmaceuticals ( CYCC ) shares surged more than 47% after the company unveiled Tuesday a private placement of about 5 million shares and warrants, targeting gross proceeds of about $8 million. More than 19.9 million shares traded intraday compared with a daily average of about 109,000. GeneDx ( WGS ) reported late...